释放基准测试的力量:实时数据分析,改善肉瘤患者的治疗结果
Bruno Fuchs1,2,3, Georg Schelling1,3, Maria Elyes1
1Sarcoma Service, University Teaching Hospital LUKS, University of Lucerne, 6000 Lucerne, Switzerland.
Cancers
|September 9, 2023
概括
使用Sarconnector®平台对肉瘤护理进行基准测试,发现多学科团队/肉瘤委员会流程的差异. 统一的数据评估是改善患者结果和降低医疗保健成本的关键.
科学领域:
- 在瘤学瘤学.
- 医疗信息学 医疗信息学
- 医疗保健管理的管理
背景情况:
- 基准测试对于提高医疗保健质量和效率至关重要,特别是对于像肉瘤这样的复杂疾病.
- 多学科团队/肉瘤委员会 (MDT/SB) 对于肉瘤管理至关重要,但过程变化可能会影响患者的结果和成本.
- 现有的国际指导方针并不完全解决MDT/SB的过程变化.
研究的目的:
- 为了比较两个MDT/SB的过程.
- 建立Sarconnector®,一个可互操作的数字平台,用于现实世界的数据评估和自动化分析.
- 评估一个统一的数据方法对瘤护理的基准测试的有用性.
主要方法:
- 包括983名患有肉瘤的患者.
- 两种不同的MDT/SB之间的数据比较.
- 利用Sarconnector®平台进行现实数据收集和分析.
主要成果:
- 在两种MDT/SB之间观察到患者呈现数量,肉瘤类型,活检率和化疗指示的差异.
- 证明了使用Sarconnector®用于真实世界的数据评估的可行性.
- 突出了工艺变化对质量和成本指标的影响.
结论:
- 使用协调数据方法对MDT/SB流程进行基准分析对于标准化护理至关重要.
- 萨尔连接器®平台及其RWT (现实世界处理) 统一的数据方法可以促进质量和成本指标评估.
- 来自基准测试的数据驱动的洞察力可以优化资源,改善患者的治疗结果,并降低肉瘤管理中的医疗保健成本.
关键词:
人工智能/机器学习 (AI/ML)临床报告结果测量 (CROMS) 是指临床医生报告的结果测量.IELAS-RWTD/E (可互操作的电子纵向绝对结构化的真实世界时间数据/证据)综合实践单位 (IPU) 是指综合实践单位.MDT/SB (多学科团队/肉瘤董事会会议)PREMS (患者体验的结果措施)患者报告结果 (PROMS) 是指患者报告的结果.SPDT (肉瘤患者的数字双胞胎)基于价值的医疗保健 (VBHC)更多相关视频
07:41Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
9.0K
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
299
相关概念视频
01:21Cancer Survival Analysis
381
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
381
01:24Kaplan-Meier Approach
178
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
178
01:20Comparing the Survival Analysis of Two or More Groups
220
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
220
01:18Introduction To Survival Analysis
273
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
273
01:20Actuarial Approach
96
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
96